# Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects

> **NCT02857777** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 37 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Esketamine

## Key facts

- **NCT ID:** NCT02857777
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-09
- **Primary completion:** 2017-01-27
- **Final completion:** 2017-01-27
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02857777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02857777, "Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly Japanese, and Healthy Younger Adult Japanese Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02857777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*